Evidence lead: Ranks seven through ten · Large request-volume cohort
BCBS Michigan MA: One of the ten largest authorization workloads
The 310,000 recorded requests place this contract in the highest-volume tier. Its request-volume rank is #9 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks seven through ten · Large request-volume cohort
One of the ten largest authorization workloads
The 310,000 recorded requests place this contract in the highest-volume tier. Its request-volume rank is #9 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks eleven through fifteen · Upper-middle appeal uptake
Appeal filing exceeded most contract records
The 3,348 filed appeals represent 15.0% of denied requests. That is rank #11 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks twenty-six through thirty · Lower-middle overturn cohort
Appeal overturns sat below the table midpoint
This contract records a 66.0% overturn rate among filed appeals. Its overturn-rate rank is #27 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Ranks twenty-six through thirty · Lower-middle reversal reach
Reversals covered a below-median share of denials
The 2,210 recorded reversals amount to 9.9% of this contract's denied requests. The cross-contract rank is #27 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.
Ranks sixteen through twenty · Upper-middle denial cohort
Above the center of the denial-rate ordering
The recorded 7.2% denial rate falls in the upper-middle portion of the contract set. The exact rank is #18 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.